News

The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than ...
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
Cumberland resident Dr. Judy Stone is an infectious disease specialist who spent 25 years in solo practice in Allegany County ...